According to Businessweek (3/12/13), Stryker announced that the FDA’s warning letter came after the agency inspected one of the company’s facilities in November 2012. Stryker noted it was cited by the FDA for not telling the FDA about a product recall and for marketing certain devices without having proper approvals.
Among the device included in the warning letter was the Neptune Waste Management System, used in hospital operating rooms to remove body fluids. Certain Neptune Rover Waste Management Systems were recalled on June 8, 2012, after reports of serious injuries - including one fatality - associated with the device. Stryker also said the company has made corrective plans to address the FDA’s concerns.
READ MORE STRYKER ORTHOPEDICS REJUVENATE LEGAL NEWS
Following the recall, Stryker recommended that surgeons consider having blood tests and cross sectional imaging done on all patients who received a Rejuvenate hip system, even if those patients were not experiencing pain or swelling. That announcement was made following reports that patients could have high metal ion levels even without showing signs of an adverse reaction.
Lawsuits have been filed linked to the Stryker Rejuvenate hip system. Some lawsuits have been consolidated in a multi-district litigation (MDL). The lawsuits allege patients suffered physical pain, mental anguish and had to pay for expensive additional medical care as a result of problems caused by the Stryker Rejuvenate.